Immediate Impact

3 by Nobel laureates 16 from Science/Nature 90 standout
Sub-graph 1 of 24

Citing Papers

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
2021 Standout
3 intermediate papers

Works of Esther de Jong being referenced

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell–attracting chemokine (CTACK) levels in allergic diseases
2004

Author Peers

Author Last Decade Papers Cites
Esther de Jong 235 133 207 170 19 761
Helga Tuschl 151 50 193 129 31 693
R.J. Dearman 120 180 388 347 26 852
Helga Rothe 159 104 183 205 27 739
H.-W. Vohr 82 58 419 344 26 897
Béatrice Le Varlet 166 65 145 274 20 757
Lars Hareng 376 91 298 57 22 974
Michaela Zorn‐Kruppa 250 40 80 262 22 873
John P. Petrali 295 56 115 186 44 948
Felix Weber 185 117 303 268 14 731
Francis H. Kruszewski 328 29 58 69 35 738

All Works

Loading papers...

Rankless by CCL
2026